US Stock MarketDetailed Quotes
IMTX Immatics
- 11.730
- 0.0000.00%
Close Sep 27 16:00 ET
- 11.730
- 0.0000.00%
Post 16:00 ET
1.21BMarket Cap-12640P/E (TTM)
11.840High11.670Low71.40KVolume11.750Open11.730Pre Close839.54KTurnover0.12%Turnover RatioLossP/E (Static)103.11MShares13.77052wk High2.79P/B672.86MFloat Cap7.15052wk Low--Dividend TTM57.36MShs Float18.420Historical High--Div YieldTTM1.45%Amplitude5.750Historical Low11.757Avg Price1Lot Size
About Immatics Company
Immatics NV is a clinical stage biopharmaceutical company, which engages in the research and development of T cell receptor-based immunotherapies for the treatment of cancer. Its pipeline includes adoptive cell therapy and TCR Bispecifics. The company was founded on March 10, 2020, and is headquartered in Tuebingen, Germany.
Company Profile
SymbolIMTX
Company NameImmatics
Listing DateJul 2, 2020
Issue Price10.00
Founded2020
CEODr. Harpreet Singh, PhD
MarketNASDAQ
Employees343
Fiscal Year Ends12-31
AddressPaul-Ehrlich-Strasse 19
CityTuebingen
ProvinceBaden Wuerttemberg
CountryGermany
Zip Code72076
Phone49-7071-5397-0
Websitehttp://www.immatics.com
Company Executives
- Name
- Position
- Salary
- Dr. Harpreet Singh, PhD
- Director and Chief Executive Officer
- 7.50M
- Arnd Christ
- Chief Financial Officer
- --
- Dr. Steffen Walter, PhD
- Chief Operations Officer
- --
- Dr. Cedrik Britten, M.D.
- Chief Medical Officer
- --
- Dr. Toni Weinschenk, PhD
- Chief Innovation Officer
- --
- Dr. Rainer Kramer, PhD
- Chief Business Officer
- --
- Dr. Carsten Reinhardt,M.D.,PhD
- Chief Development Officer
- --
- Peter Alan Chambre
- Chairman of the Board
- 283.00K
- Edward Sturchio, J.D.
- General Counsel
- --
- Dr. Eliot Richard Forster, M.B.A.,PhD
- Member of the Supervisory Board
- 249.00K
- Michael G. Atieh
- Member of the Supervisory Board
- 263.00K
- Jordan Silverstein
- Head of Strategy
- --
- Dr. Mathias Hothum, PhD
- Member of the Supervisory Board
- 120.00K
- Heather L. Mason
- Member of the Supervisory Board
- 246.00K
- Paul Rutherford Carter
- Member of the Supervisory Board
- 259.00K
- Adam Stone
- Member of the Supervisory Board
- 246.00K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data